3 documents found, page 1 of 1
The World Heart Federation global study on COVID-19 and cardiovascular disease
Sliwa, Karen; Singh, Kavita; Raspail, Lana; Ojji, Dike; Lam, Carolyn S.P.; Thienemann, Friedrich; Ge, Junbo; Banerjee, Amitava; Newby, L. KristinBackground: The emergence of novel coronavirus disease 2019 (COVID-19), caused by the Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2), has presented an unprecedented global challenge for the healthcare community. The ability of SARS-CoV-2 to get transmitted during the asymptomatic phase, and its high infectivity have led to the rapid transmission of COVID-19 beyond geographic regions facilitated by...
Overview of the current status of familial hypercholesterolaemia care in over 6...
EAS Familial Hypercholesterolaemia Studies Collaboration; Vallejo-Vaz, Antonio J.; De Marco, Martina; Stevens, Christophe A.T.; Akram, AsifManagement of familial hypercholesterolaemia (FH) may vary across different settings due to factors related to population characteristics, practice, resources and/or policies. We conducted a survey among the worldwide network of EAS FHSC Lead Investigators to provide an overview of FH status in different countries.
Acutely decompensated heart failure with preserved and reduced ejection fractio...
Van Aelst, Lucas N.L.; Arrigo, Mattia; Plácido, Rui; Akiyama, Eiichi; Girerd, Nicolas; Zannad, Faiez; Manivet, Philippe; Rossignol, Patrick; Badoz, MarcAims: Congestion is a central feature of acute heart failure (HF) and its assessment is important for clinical decisions (e.g. tailoring decongestive treatments). It remains uncertain whether patients with acute HF with preserved ejection fraction (HFpEF) are comparably congested as in acute HF with reduced EF (HFrEF). This study assessed congestion, right ventricular (RV) and renal dysfunction in acute HFpEF, ...